In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tianjin chosen for China nanotech cancer diagnostics research centre:

This article was originally published in Clinica

Executive Summary

China has launched a research centre specialising in developing nanotech solutions for cancer diagnosis and treatment. The Tianjin-based centre is a joint venture between the Chinese Academy of Sciences, the Institute of High Energy Physics, the National Center for Nanoscience & Technology and the Tianjin Medical University Cancer Institute and Hospital. It will provide an interdisciplinary research platform, for those working on developing nanotech in the field of oncology, according to the Asia-Pacific life sciences business magazine BioSpectrum.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts